All Articles Tagged With: "Bextra"
Articles
Pfizer Faces Criminal Investigation Over Rapamune Marketing
Federal prosecutors have opened a criminal investigation into Wyeth’s promotions and marketing activities involving the organ transplant drug Rapamune.
Drug Maker Sues FDA Over Ban on Offering Doctors Info About Off-Label Uses
The makers of Botox filed a lawsuit last week against the FDA, challenging federal regulations that ban drug companies from marketing drugs for uses that they have not been established as safe and effective through the FDA approval process.
Pfizer Settles Fraudulent Marketing Claims for $2.3B Fine
To resolve criminal and civil claims over the illegal marketing of the recalled painkiller Bextra and other drugs, Pfizer has agreed to pay $2.3 billion. It is the fourth Pfizer settlement relating to illegal marketing of their products since 2002, and includes the largest criminal fine in U.S. history.
Celebrex and Bextra Settlements Resolve 90% of Litigation
On Friday, Pfizer confirmed that they have reached agreements in principal to settle Bextra and Celebrex lawsuits filed by individuals who suffered injuries like heart attacks and strokes, as well as consumer fraud and state attorney general claims. The settlements will resolve more than 90% of the known lawsuits Pfizer faces involving the drugs. [...]
Celebrex and Bextra Lawsuit Settlements Reported
Pfizer, Inc. has begun discussing settlement for some Celebrex and Bextra lawsuits pending throughout the United States. According to the Wall Street Journal, the pharmaceutical company which sold both pain medications, has reached tentative deals with some individuals who suffered heart attacks or strokes which were associated with use of the drugs.
